Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Ann Quinlan-Colwell

Ann Quinlan-Colwell

New Hanover Regional Medical Center, USA

Title: Use of the Pasero Opioid-Induced Sedation Scale (POSS) in Pediatric Patients

Biography

Biography: Ann Quinlan-Colwell

Abstract

The Pasero Opioid-Induced Sedation Scale (POSS) is a valid, reliable tool used to assess sedation when administering opioid medications to manage pain. POSS is endorsed by The Joint Commission and the American Society for Pain Management Nursing to help prevent adverse opioid-related respiratory events. Although POSS is used to assess sedation in pediatric patients at some hospitals, it was not formally evaluated in the pediatric population. This study used a quasi-experimental design with a convenience sample of pediatric patients admitted to a large regional medical center. POSS was evaluated from three perspectives. First the study was designed to compare documentation of sedation when opioids were administered before (n = 25) and after (n = 27) implementation of POSS to assess sedation. Second, occurrence of respiratory adverse events before and after implementation was compared. Third, appropriateness of using  POSS in pediatric population was evaluated. When POSS was used, there was an increase in both clarity and frequency of documentation when sedation was assessed. There was no incidence of opioid-related adverse respiratory events after implementation of POSS. Finally, POSS was found to be appropriate and safe to use in pediatric population. Through survey, the majority of registered nurses who cared for the research subjects evaluated POSS as easy, appropriate and safe to use with pediatric patients. The nurses also noted using POSS provided standardized communication among staff regarding patients’ levels of sedation. No adverse effects, concerns, or objections were reported. Coincidentally, frequency of documentation of assessment of pain also improved with POSS.